Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. This is an exciting opportunity to advance novel inhibitors through drug discovery and development stages. The ideal candidate has experience in project management with a thorough understanding of the relevant science and technologies associated with activities ranging from target validation through early development including activities supporting Investigational New Drug (IND) applications and approvals. This position will be partnered closely with the Program Management functional lead, Program Team Leader and scientific functional leads to drive the execution of program initiatives to meet business objectives.